| 1ZZW |
1.6 |
Crystal Structure of catalytic domain of Human MAP Kinase Phosphatase 5 |
| 2OUC |
2.2 |
Crystal structure of the MAP kinase binding domain of MKP5 |
| 2OUD |
2.8 |
Crystal structure of the catalytic domain of human MKP5 |
| 3TG1 |
2.71 |
Crystal structure of p38alpha in complex with a MAPK docking partner |
| 6MC1 |
2.7 |
Structure of MAP kinase phosphatase 5 in complex with 3,3-dimethyl-1-((9-(methylthio)-5,6-dihydrothieno[3,4-h]quinazolin-2-yl)thio)butan-2-one, an allosteric inhibitor |
| 7U4O |
2.3 |
Structure of MAP kinase phosphatase 5 in complex with 3,3-dimethyl-1-((9-propyl-5,6-dihydrothieno[3,4-h]quinazolin-2-yl)thio)butan-2-one, an allosteric inhibitor |
| 7U4R |
3.14 |
Structure of MAP kinase phosphatase 5 in complex with 3,3-dimethyl-1-((9-propyl-5,6-dihydrothieno[2,3-h]quinazolin-2-yl)thio)butan-2-one, an allosteric inhibitor |
| 7UMU |
2.51 |
Structure of MAP kinase phosphatase 5 in complex with 3,3-dimethyl-1-((5,6-dihydrobenzo[h]quinazolin-2-yl)thio)butan-2-one, an allosteric inhibitor |
| 7UMV |
1.8 |
Structure of MAP kinase phosphatase 5 in complex with 3,3-dimethyl-1-((5,6-dihydropyrido[2,3-h]quinazolin-2-yl)thio)butan-2-one, an allosteric inhibitor |
| 7UN0 |
3.0 |
Structure of MAP kinase phosphatase 5 in complex with 3,3-dimethyl-1-((9-chloro-5,6-dihydrobenzo[h]quinazolin-2-yl)thio)butan-2-one, an allosteric inhibitor |
| 7UN4 |
2.7 |
Structure of MAP kinase phosphatase 5 in complex with 3,3-dimethyl-1-((9-propyl-5,6-dihydrothieno[3,4-h]quinazolin-2-yl)thio)butan-2-one, an allosteric inhibitor |
